Viewing Study NCT06157151

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-05-29 @ 1:49 AM
Study NCT ID: NCT06157151
Status: RECRUITING
Last Update Posted: 2025-11-14
First Post: 2023-11-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
Sponsor: Precigen, Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cervical Cancer View
None HPV-Related Carcinoma View
None HPV-Related Malignancy View
None Recurrent Cervical Carcinoma View
None Metastatic Cervical Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Human Papilloma Virus View
None Cervical Cancer View
None Pembrolizumab View
None Therapeutic Vaccine View
None Cervix Cancer View
None Resistance to Checkpoint Inhibitors View